Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome

NCT01253629 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Fragile X Syndrome

Interventions

DRUG: AFQ056
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals